Jonathan C. Roberts - Feb 21, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & Chief Operating Officer
Signature
Jonathan C. Roberts
Stock symbol
CVS
Transactions as of
Feb 21, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:32 PM
Previous filing
Jan 28, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $0 +322K +311.1% $0.00 426K Feb 21, 2022 Direct F1
holding CVS Common Stock 38.2K Feb 21, 2022 By GRAT
holding CVS Common Stock (restricted) 12.8K Feb 21, 2022 Direct
holding CVS ESOP Common Stock 6.05K Feb 21, 2022 By ESOP
holding CVS Stock Unit 341K Feb 21, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Phantom Stock Credits 1.42K Feb 21, 2022 Common Stock 1.42K $1.00 Direct F2
holding CVS Stock Option 161K Feb 21, 2022 Common Stock 161K $104.82 Direct F3
holding CVS Stock Option 200K Feb 21, 2022 Common Stock 200K $78.05 Direct F4
holding CVS Stock Option 248K Feb 21, 2022 Common Stock 248K $62.21 Direct F5
holding CVS Stock Option 303K Feb 21, 2022 Common Stock 303K $54.19 Direct F6
holding CVS Stock Option 239K Feb 21, 2022 Common Stock 239K $58.34 Direct F7, F8
holding CVS Stock Option 173K Feb 21, 2022 Common Stock 173K $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal installments, commencing 4/1/2022.